Trial Profile
Double-blind, parallel-group, controlled Phase 3 study of MRA in rheumatoid arthritis(RA)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 17 Jun 2016 New trial record